Haemolysin produced by a clinical isolate of Morganella morganii was examined for antigenic relatedness to the haemolysin of Escherichia coli and for similarities in mode of action. The M . morganii haemolysin migrated in SDS-PAGE as a single protein band with a slightly higher molecular weight than that of E. coli haemolysin. Several murine monoclonal antibodies against E . coli haemolysin crossreacted with the M . morganii haemolysin in Western blots. Diminished haemolysis in the presence of osmotically-stabilising solutes indicated the formation of a pore by M . morganii haemolysin with an effective diameter of 1.5-3 nm. Results from doseresponse experiments indicated that a single "hit" was sufficient for lysis of an erythrocyte. Detergent solubilisation of toxin-treated membranes led to recovery of bound toxin exclusively in monomeric form. M . rnorganii haemolysin was a potent leucocidin, that caused rapid leakage of ATP and death of human polymorphonuclear leucocytes. Under in-vitro conditions M . morganii haemolysin displayed similar leucocidal and haemolytic efficiency. The data demonstrate that M . morganii haemolysin shows functional properties haemol ysin.
Introduction
In a recent study, 56% of clinical isolates of Morganella morganii were haemolytic and produced a filterable haemolysin.' Production of this haemolytic toxin appeared to be a virulence factor because intranasal application of haemolytic strains in mice caused death within a short time and haemorrhagic lung oedema was found at autopsy. * Moreover, in an intraperitoneal virulence assay, mice receiving haemolytic strains developed haemoglobinuria, and the LD50 was 10 times lower than that of non-haemolytic strains. Because of their similar biological effects, Emody et al.' predicted that M . morganii and Escherichia coli haemolysins might be structurally related to each other.
Recently, clear, albeit incomplete, homology between the regions encoding production of haemolysins in M . morganii, E. coli and Proteus spp. and of leucotoxins of Pasteurella haemolytica and Actinobacillus actinomycetemcomitans were found by Southern hybridisation experiments. - [3] [4] [5] [6] [7] These cytolysins thus form a newly recognised family of toxins that may have a similar mode of action, Received 5 Jan. 1990 ; accepted 3 April 1990. *Correspondence should be sent to Dr S. Bhakdi. virtually identical with those of E. coli because of similarities in their predicted protein structure. Functional studies have demonstrated that the cytolysins of E. coli and P. haemolytica exert their cytotoxic action by generating discrete transmembrane pores in the plasma membranes of target cell^.^.^ In vitro, E. coli haemolysin acts on erythrocytes of many species," and on renal tubular cells;' ' it has recently been identified as a powerful leucocidin.' ' In contrast, the P. haemolytica cytolysin has minimal haemolytic activity and attacks only leucocytes of ruminants.
The purpose of the present study was to obtain information on the mode of action of M . morganii haemolysin and compare it with that of E. coli haemolysin.
Materials and methods

Preparation of haemolysins
The haemolytic M . morganii strain used for production of haemolysin was isolated in our laboratory from a wound swab. It was identified to species level by means of the API 20E test kit (Bio Merieux, Nurtingen, FRG). From an overnight culture, 100 pl were added to 20 ml of ToddHewitt Broth (Difco Laboratories, Detroit, MI, USA) containing 10 mM CaC12. After incubation in a waterbath at 37°C with agitation for 3.5 h, the bacteria were pelleted by centrifugation ( 5 min, 20 000 g) and the supernatant fluid was filtered (Millex GV 4, 0.22pm, low protein binding; Millipore, Eschborn, FRG). In some experiments these crude supernates (haemolytic titres usually 32-64 HU/ml) were used without further processing ; in others, the haemolysin was concentrated by precipitation with polyethylene glycol 4000 20% as described previously for E. coli haemolysh8 The precipitates, obtained from 20 ml of supernate and dissolved in 200 pl of distilled water, yielded titres of 500-2000 HU/ml. E. coli haemolysin was prepared as described previously. 8 Titrations for determination of haemolytic activity were performed as described previously : I 4 a haemolysin dilution lysing 60% of a rabbit erythrocyte suspension, 10% in phosphate-buffered saline, within 1 h at 37°C was defined as containing 1 HU of toxin/ml.
Cross-reaction of E. coli haemolysin-antibodies with M . morganii haemolysin
Western blots of M . morganii haemolysin were performed according to a protocol already described' ' and developed with murine monoclonal anti bodies raised against E. coli haemolysin.
Sucrose density centrifugation of haemolysin-treated erythrocyte membranes
Sheep erythrocytes were treated with M . morganii haemolysin (final concentration 80 HU/ml) for 1 h at 37°C. The membranes were washed, solubilised with 250 mM deoxycholate detergent and centrifuged in a 10-50% w/v sucrose density gradient (1 50 000 g, 16 h, 4°C). Ten equal fractions were collected from each gradient and analysed by immunoblotting. 8 
Efect of erythrocyte concentration on number of lysed cells
The experiment followed the protocol of Jorgensen et al. 7-200-pl samples of cell suspensions containing (0.5-28) x lo8 cells/ml were incubated with 200 p1 of toxin (final toxin concentration 0.1 or 0.05 HU/ml), or with 20Opl of PBS. After 60min at 37°C' haemolysis was determined spectrophotometrically. For each erythrocyte concentration, the average reading of three tubes minus the average reading of three blank tubes was determined. The number of lysed erythrocytes was calculated by comparing the absorbance with that of samples completely lysed by detergent.
Osmotic protect ion experiments
and dextran 4 (M, c. 4000-6000) (Serva, Heidelberg, FRG). Haemolysin was serially diluted in carbohydratefree buffer and one volume of rabbit erythrocyte suspension was added to each sample. Haemolysis was read after 60 min at 37°C by measurement of haemoglobin absorbance at 412 nm in the supernates. The dilution of toxin causing 60% haemolysis was determined with each protective substance. The haemolytic titre recorded was compared with the control titre obtained in the absence of the carbohydrates. In the presence of dextran 4 the erythrocytes did not lyse. They were then washed thrice in dextran-containing buffer, resuspended in dextranfree buffer, and the haemolytic titre was determined after incubation for 60 min at 37°C.
Toxin-induced transmembrane K + -and 4'Ca2 +-fluxes were detected by measuring changes in the concentrations of the ions in the supernates of dextran-protected erythrocytes.
A TP-release from polymorphonuclear leucocytes ( P M N L )
Human PMNL were isolated as described previously.' ATP-efflux from the cells was detected by the firefly assay and continuously recorded by means of a Whole-blood Aggrometer (model 500 VS, Chrono Log Corporation, Haverton, USA) equipped with a 2210 2-channel Recorder (Pharmacia LKB, Bromma, Sweden): 170 pl of PBS was pre-warmed to 37°C and 170 pl of firefly reagent (ATP Bioluminescence CLS, Boehringer, Mannheim, FRG) and 40 p1 of PMNL suspension ( 5 x lo7 cells/ml) were added. After 60 s, 10 pl of haemolysin were added to give a final concentration of haemolysin in the range 0.005-10 HU/ml.
In a second assay, haemolysin was serially diluted in 100 p1 of Hanks's Balanced Salts Solution (HBSS) and 15 pl of a cell suspension (5 x lo7 cells/ml) were added to each sample. After 1 h at 37"C, the residual ATP-content of the cells was determined in the following manner: 30 pl of a cell sample were pipetted into 300 p1 of a prewarmed (37°C) solution of firefly reagent containing 3 mM Triton X-100 (Serva, Heidelberg, FRG). The detergent caused instant disruption of the plasma cell membrane, and liberated cellular ATP could be quantified by bioluminescence. The ATP-content of the cells was expressed as the percentage of that of the controls. Haemolytic assays were performed in parallel with the same haemolysin preparations and employing similar target-cell concentrations ( 5 x 1 O7 erythrocytes/ml). Additionally the same experiments were conducted in the presence of autologous serum instead of buffer.
Results
Rabbit erythrocytes (5 X lo8 cells/ml) w~e suspended in buffer (90 mM NaC1,45 mM KCl, 12.5 mM phosphate, pH 7-2) containing one of the following substances (60 mM) : erythrol, arabinose, sucrose, raffinose (Merck AG, Darmstadt, FRG), dextran FP1 (M, c. 900-1200) 
Electrophoretic behaviour of M . morganii haemolysin
Culture supernates harvested in the late logphase displayed titres of 64-1 28 HU/ml. Haemolytic activity was lost on standing (at 37°C within hours, at 0°C within 1 day). Concentrated haemolysin samples obtained by PEG-precipitation yielded titres of 500-2000 HU/ml. These haemolysin preparations exhibited a single protein band in sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) with an apparent molecular weight slightly above that of E. coli haemolysin (Mr 107 000). Polyclonal rabbit antiserum against E. coli haemolysin cross-reacted strongly with the M . morganii haemolysin in Western blots. A panel of monoclonal murine antibodies raised against E. coli haemolysin16 also cross-reacted with the M . morganii haemolysin ( fig. 1) .
Osmotic protection experiments
The presence of a sugar or a dextran reduced the haemolytic titre to an extent that depended on the size of the added substance and on the length of incubation ( fig. 2) . Erythrol (molecular radius 0.28 nm) caused no significant reduction in titre, whereas molecules with radii of 0.3-0.8 nm reduced the speed of lysis. Dextran 4 (molecular radius% 1.5 nm) protected erythrocytes and, after incubation for 60 min, no haemolysis was found even at high haemolysin doses. In the latter case, unbound toxin was removed by washing the cells in buffer containing dextran 4. Subsequent incubation of these cells in dextran-free buffer resulted in haemolysis, showing that protection of erythrocytes by dextran 4 was not due to an inhibition of haemolysin binding to the cells.
The existence of pores in membranes of dextranprotected cells was confirmed by measurements of ion fluxes. As shown in fig. 3 , a very rapid efflux of K + and a parallel influx of 45Ca2f into the cells occurred that was complete within 1-2 min following haemolysin application.
Egect of' erythrocyte concentration on number of lysed erythrocytes
When a constant amount of M . morganii haemolysin was added to erythrocyte suspensions containing increasing numbers of cells, the amount of released haemoglobin increased with increasing cell concentrations up to a maximum value (fig. 4) . Doubling of haemolysin concentration doubled the number of lysed cells. This dose-response behaviour indicates a "single hit" mechanism of cell lysis."
Properties of membrane-bound toxin
Membranes of haemoglobin-treated erythrocytes were solubilised with deoxycholate and centrifuged through a sucrose density gradient. Subsequent analysis of the density gradient fractions by SDS-PAGE and Western blotting showed that M . morganii haemolysin was present exclusively in monomeric form in detergent. The results (not shown) were identical with those previously obtained with E. coli haemolysin.*
EfSect of M . morganii haemolysin on P M N L
Application of M . morganii haemolysin to human PMNL evoked rapid release of ATP, lag periods of seconds being noted at moderate haemolysin doses. With decreasing haemolysin doses, the lag phase between toxin application and commencement of ATP-release increased ( fig. 5A ). In a second type 
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A haemolysin that evoked ATP-depletion corresponded exactly with haemolytic activity, which indicates that the leucocidal potency of M . morganii protein-free buffer. When cells were suspended in autologous serum, erythrocytes were found to be protected from lysis by up to 50 HU/ml of the M .
cumbed to attack by only 10HU/ml of the haemolysin in the same conditions. fig. 5B , concentrations of
The properties of native M . morganii haemolysin resembled those of E. coli haemolysin. In SDS-PAGE the M . morganii haemolysin displayed a slightly higher molecular weight than E. coli haemolysin. Cross-reaction of monoclonal antibodies with both haemolysins indicated the presence of common epitopes. Like that of other members of this family of toxins, the activity of M . morganii haemolysin seems to be calcium-dependent. Haemolysin produced by bacteria grown in medium without calcium supplementation showed virtually no haemolytic activity, but could be "activated" by addition of 10mM CaC1,. After standing, the haemolysin of M . morganii, lost activity at a rate similar to that of E. coli haemolysin. The nature of this inactivation process remains unknown, but does not appear to be due to proteolysis.8 The M . morganii haemolysin causes haemolysis by generating a pore in the erythrocyte membrane. Addition of 30mM dextran 4 to the incubation buffer prevented haemolysin-induced lysis of erythrocytes, whilst rapid leakage of K f and influx of "'Ca' + could be measured in these cells. Dextran 4 is obviously too large to pass the haemolysin pore and prevents rupture of the erythrocytes by counterbalancing the intracellular colloid-osmotic pressure exerted by haemoglobin. On the basis of the osmotic protection experiments, we estimate a functional pore diameter of 1.5-3 nm, equivalent to the estimated size of the E. coli haemolysin pore. 8,2 '
That the haemolytic efficacy of a given amount of M . morganii haemolysin was not diminished by the addition of large numbers of potential target cells indicated that a single haemolysin "hit" was sufficient for the lysis of an erythrocyte. After detergent-solubilisation of haemolysin-treated membranes, bound haemolysin was found exclusively in monomeric form. Analogous experiments have yielded similar results with E. coli haemolysin,8*'7 which leads to the conclusion that E. coli haemolysin generates pores by insertion as a monomer into the membrane.
Because E. coli haemolysin has recently been demonstrated to exhibit great leucocidal potency,' we tested the possibility that the M . morganii haemolysin might also attack human granulocytes. M . morganii haemolysin caused leakage of ATP and death of attacked cells. In our assay, the leucocidal efficiency of M . morganii haemolysin was as high as its haemolytic efficiency when cells were suspended in protein-free buffer, but if titrations were done in autologous serum, the leucocidal effect clearly surpassed haemolytic capacity. Similar findings have been reported for E. coli haemolysin. ' In conclusion, all the data have shown complete parallelism between the action of M . morganii haemolysin and E. coli haemolysin on human erythrocytes and PMNL. Within the family of
